![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: PCAT7 |
Gene summary for PCAT7 |
![]() |
Gene information | Species | Human | Gene symbol | PCAT7 | Gene ID | 101928099 |
Gene name | prostate cancer associated transcript 7 | |
Gene Alias | PCAN-R2 | |
Cytomap | 9q22.32 | |
Gene Type | ncRNA | GO ID | NA | UniProtAcc | NA |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
101928099 | PCAT7 | HCC1 | Human | Liver | HCC | 9.01e-03 | 7.24e-01 | 0.5336 |
101928099 | PCAT7 | HCC2 | Human | Liver | HCC | 2.51e-17 | 1.49e+00 | 0.5341 |
101928099 | PCAT7 | HCC5 | Human | Liver | HCC | 2.19e-21 | 1.41e+00 | 0.4932 |
101928099 | PCAT7 | S015 | Human | Liver | HCC | 1.49e-03 | 2.33e-01 | 0.2375 |
101928099 | PCAT7 | C04 | Human | Oral cavity | OSCC | 3.41e-02 | 1.71e-01 | 0.2633 |
101928099 | PCAT7 | C21 | Human | Oral cavity | OSCC | 8.63e-03 | 1.18e-01 | 0.2678 |
101928099 | PCAT7 | C38 | Human | Oral cavity | OSCC | 5.51e-08 | 6.00e-01 | 0.172 |
101928099 | PCAT7 | C46 | Human | Oral cavity | OSCC | 1.02e-15 | 3.51e-01 | 0.1673 |
101928099 | PCAT7 | C06 | Human | Oral cavity | OSCC | 1.27e-02 | 3.97e-01 | 0.2699 |
101928099 | PCAT7 | C08 | Human | Oral cavity | OSCC | 1.93e-05 | 1.30e-01 | 0.1919 |
101928099 | PCAT7 | LN38 | Human | Oral cavity | OSCC | 5.78e-10 | 7.36e-01 | 0.168 |
101928099 | PCAT7 | LN46 | Human | Oral cavity | OSCC | 1.77e-13 | 3.39e-01 | 0.1666 |
Page: 1 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Cervix | N_HPV | ![]() |
Endometrium | AEH | ![]() |
Endometrium | EEC | ![]() |
Prostate | BPH | ![]() |
Prostate | Tumor | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
Page: 1 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |